Noninvasive Ventilation and Lung Volume Reduction

https://doi.org/10.1016/j.ccm.2013.10.011Get rights and content

Section snippets

Key points

  • Noninvasive ventilation given to patients with acute hypercapnic exacerbation of chronic obstructive pulmonary disease reduces mortality and morbidity.

  • Lung volume reduction surgery is effective in patients with heterogeneous upper zone emphysema and reduced exercise tolerance, and is probably underused.

  • Rapid progress is being made in nonsurgical approaches to lung volume reduction, but use outside specialized centers cannot be recommended presently.

NIV

NIV provides ventilatory support without the need for endotracheal intubation and thus supports the respiratory muscle pump both by reducing the work of breathing and by improving tidal volume.2 The ability to provide ventilatory support without the need for invasive mechanical ventilation has been one of the major advances in the management of acute respiratory failure complicating exacerbations of COPD. The use of NIV during decompensated hypercapnic respiratory failure secondary to acute

Indications

Acute exacerbations of COPD represent a dynamic shift in the load-capacity-drive relationship of the respiratory system caused by an increased load exerted on it.6 The increased load is mediated principally via changes in both inspiratory resistance and dynamic chest wall elastance, as well as a threshold load exerted by intrinsic PEEP.7 This acute increase in load on the respiratory system causes a significant increase in the work of breathing, with transdiaphragmatic pressure changes in

Physiologic Basis

The development of hypercapnic respiratory failure in COPD occurs because of an imbalance in the load-capacity-drive relationship of the respiratory system and confers a poor prognosis, with significant morbidity and mortality.26, 27 The use of ventilatory support to correct respiratory failure in this context has empirical appeal and is suggested to work via 3 main hypotheses:

  • 1.

    Resetting central respiratory drive

  • 2.

    Improving pulmonary mechanics

  • 3.

    Resting chronically fatigued respiratory muscles

The

Physiologic Basis

Emphysema is characterized by damage and destruction of the alveoli and airspaces distal to the terminal bronchioles diminishing the alveolar surface area available for gas exchange. This loss of the alveolar wall, structural elements, and pulmonary vasculature leads to reduced elastic recoil, as well as narrowing of the airways caused by the loss of the outward tension that maintains their patency. Airways are thus compressed and can collapse under the positive intrathoracic pressure of

Summary

At the time of writing, the only established therapy is surgical LVR, which is indicated for hyperinflated patients with heterogeneous upper zone disease who exceed the NETT safety criteria and who experience symptoms despite rehabilitation. Pivotal trials of several nonsurgical techniques are underway and should inform on efficacy, safety, and optimal patient selection within the next 3 to 5 years. Long-term safety and efficacy data for these novel bronchoscopic techniques are lacking but will

First page preview

First page preview
Click to open first page preview

References (102)

  • M.I. Polkey et al.

    Noninvasive ventilation in the management of decompensated COPD

    Monaldi Arch Chest Dis

    (1995)
  • S. Nava et al.

    Effect of nasal pressure support ventilation and external PEEP on diaphragmatic activity in patients with severe stable COPD

    Chest

    (1993)
  • British Thoracic Society Standards of Care Committee

    Non-invasive ventilation in acute respiratory failure

    Thorax

    (2002)
  • Organized jointly by the American Thoracic Society et al.

    International consensus conferences in intensive care medicine: noninvasive positive pressure ventilation in acute respiratory failure

    Am J Respir Crit Care Med

    (2001)
  • M.W. Elliott

    Domiciliary non-invasive ventilation in stable COPD?

    Thorax

    (2009)
  • A. Purro et al.

    Mechanical determinants of early acute ventilatory failure in COPD patients: a physiologic study

    Intensive Care Med

    (2009)
  • A. Jubran et al.

    Pathophysiologic basis of acute respiratory distress in patients who fail a trial of weaning from mechanical ventilation

    Am J Respir Crit Care Med

    (1997)
  • L. Brochard et al.

    Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face mask

    N Engl J Med

    (1990)
  • F. Laghi et al.

    Effect of lung volume reduction surgery on diaphragmatic neuromechanical coupling at 2 years

    Chest

    (2004)
  • L. Dal Vecchio et al.

    “Intrinsic” positive end-expiratory pressure in stable patients with chronic obstructive pulmonary disease

    Eur Respir J

    (1990)
  • C.M. Chu et al.

    Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure

    Thorax

    (2004)
  • J. Bott et al.

    Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease

    Lancet

    (1993)
  • L. Brochard et al.

    Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease

    N Engl J Med

    (1995)
  • N. Kramer et al.

    Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure

    Am J Respir Crit Care Med

    (1995)
  • P.K. Plant et al.

    Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial

    Lancet

    (2000)
  • N. Ambrosino et al.

    Non-invasive mechanical ventilation in acute respiratory failure due to chronic obstructive pulmonary disease: correlates for success

    Thorax

    (1995)
  • P.K. Myint et al.

    National COPD resources and outcomes project 2008: patients with chronic obstructive pulmonary disease exacerbations who present with radiological pneumonia have worse outcome compared to those with non-pneumonic chronic obstructive pulmonary disease exacerbations

    Respiration

    (2011)
  • G.W. Soo Hoo et al.

    Nasal mechanical ventilation for hypercapnic respiratory failure in chronic obstructive pulmonary disease: determinants of success and failure

    Crit Care Med

    (1994)
  • G.G. Diaz et al.

    Noninvasive positive-pressure ventilation to treat hypercapnic coma secondary to respiratory failure

    Chest

    (2005)
  • G.U. Meduri et al.

    Noninvasive positive pressure ventilation via face mask. First-line intervention in patients with acute hypercapnic and hypoxemic respiratory failure

    Chest

    (1996)
  • M.J. Wildman et al.

    Implications of prognostic pessimism in patients with chronic obstructive pulmonary disease (COPD) or asthma admitted to intensive care in the UK within the COPD and Asthma Outcome Study (CAOS): multicentre observational cohort study

    BMJ

    (2007)
  • F. Fanfulla et al.

    Effects of different ventilator settings on sleep and inspiratory effort in patients with neuromuscular disease

    Am J Respir Crit Care Med

    (2005)
  • S.D. Miller et al.

    High inspiratory pressures are tolerated by patients with acute COPD requiring noninvasive ventilation

    Eur Respir J

    (2009)
  • S.D. Miller et al.

    The duration of non-invasive ventilation is associated with outcome in acute COPD

    Eur Respir J

    (2009)
  • F. Di Marco et al.

    Optimization of ventilator setting by flow and pressure waveforms analysis during noninvasive ventilation for acute exacerbations of COPD: a multicentric randomized controlled trial

    Crit Care

    (2011)
  • A.F. Connors et al.

    Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)

    Am J Respir Crit Care Med

    (1996)
  • I. Murray et al.

    Outcomes following non-invasive ventilation for hypercapnic exacerbations of chronic obstructive pulmonary disease

    Thorax

    (2011)
  • C.H. Hamnegard et al.

    Maximum rate of change in oesophageal pressure assessed from unoccluded breaths: an option where mouth occlusion pressure is impractical

    Eur Respir J

    (1998)
  • M. Montes de Oca et al.

    Mouth occlusion pressure, CO2 response and hypercapnia in severe chronic obstructive pulmonary disease

    Eur Respir J

    (1998)
  • C.J. Jolley et al.

    Neural respiratory drive in healthy subjects and in COPD

    Eur Respir J

    (2009)
  • A.H. Nickol et al.

    Mechanisms of improvement of respiratory failure in patients with COPD treated with NIV

    Int J Chron Obstruct Pulmon Dis

    (2008)
  • M.W. Elliott et al.

    Domiciliary nocturnal nasal intermittent positive pressure ventilation in COPD: mechanisms underlying changes in arterial blood gas tensions

    Eur Respir J

    (1991)
  • D.J. Read

    A clinical method for assessing the ventilatory response to carbon dioxide

    Australas Ann Med

    (1967)
  • W.A. Whitelaw et al.

    Occlusion pressure as a measure of respiratory center output in conscious man

    Respir Physiol

    (1975)
  • S. Nava et al.

    Physiologic evaluation of 4 weeks of nocturnal nasal positive pressure ventilation in stable hypercapnic patients with chronic obstructive pulmonary disease

    Respiration

    (2001)
  • O. Diaz et al.

    Effects of noninvasive ventilation on lung hyperinflation in stable hypercapnic COPD

    Eur Respir J

    (2002)
  • A.J. Moore et al.

    Sniff nasal inspiratory pressure versus IC/TLC ratio as predictors of mortality in COPD

    Respir Med

    (2010)
  • O. Diaz et al.

    Physiological and clinical effects of diurnal noninvasive ventilation in hypercapnic COPD

    Eur Respir J

    (2005)
  • P. Laveneziana et al.

    Evolution of dyspnea during exercise in chronic obstructive pulmonary disease: impact of critical volume constraints

    Am J Respir Crit Care Med

    (2011)
  • A.K. Stubbings et al.

    Physiological properties of human diaphragm muscle fibres and the effect of chronic obstructive pulmonary disease

    J Physiol

    (2008)
  • S. Levine et al.

    Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease

    N Engl J Med

    (1997)
  • M.I. Polkey et al.

    Diaphragm performance during maximal voluntary ventilation in chronic obstructive pulmonary disease

    Am J Respir Crit Care Med

    (1997)
  • F. Laghi et al.

    Is weaning failure caused by low-frequency fatigue of the diaphragm?

    Am J Respir Crit Care Med

    (2003)
  • E. Clini et al.

    The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients

    Eur Respir J

    (2002)
  • C. Casanova et al.

    Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD

    Chest

    (2000)
  • S.H. Shapiro et al.

    Effect of negative pressure ventilation in severe chronic obstructive pulmonary disease

    Lancet

    (1992)
  • P.J. Wijkstra et al.

    Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease

    Cochrane Database Syst Rev

    (2002)
  • D.A. Strumpf et al.

    Nocturnal positive-pressure ventilation via nasal mask in patients with severe chronic obstructive pulmonary disease

    Am Rev Respir Dis

    (1991)
  • J.A. Fleetham et al.

    Regional lung function in the presence of pleural symphysis

    Am Rev Respir Dis

    (1980)
  • R.D. McEvoy et al.

    Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial

    Thorax

    (2009)
  • This work was supported in part by the NIHR Respiratory Biomedical Research Unit, which part funds the salary of M.I. Polkey and wholly funds the salary of Z. Zoumot. Z. Zoumot’s institution has received reimbursement for trial expenses from PneumRx, Spiration, and Broncus. P. Murphy was previously supported by a grant for a study cofounded by ResMed and Respironics. M.I. Polkey receives fees for consulting from Respironics, Broncus, and PortAero, and his institution held on his behalf an award from PortAero for clinical research.

    1

    Drs P. Murphy and Z. Zoumot contributed equally to this article.

    View full text